氮芥苯甲酸氧化二丁基锡复合物的合成、晶体结构及其体外抗癌活性研究

Di-n-butyltin oxide reacted with p-[N,N-bis（2-chloroethyl）amino]benzoic acid to yield the compounds {{4-[（ClCH2CH2）2N]C6H4COOSnBu2}2O}2 （1） and {4-[（ClCH2CH2）2N]C6H4COO}2SnBu2 （2）, which have been characterized by IR and ^1H NMR spectra. The X-ray diffractional studies of 1 reveal the structure of the molecule to be a dimer, in which the two Bu2Sn groups were linked via two bridging oxygen atoms to form a central Bu4Sn2O2 unit. And the tin atom adopts two carbons from two n-butyl groups and three oxygen atoms from the acid and the bridging oxygen. In vitro test showed compound 1 to exhibit high cytotoxicity against P388 and HL-60 cell lines.     

某些元素有机化合物抗癌活性的研究

本文综述了一些元素有机化合物抗癌活性的最新研究方向。     

哌嗪取代卟啉的合成、表征及其抗癌活性

设计并合成了6个具有抗癌活性的哌嗪取代卟啉化合物,分别为5,10,15,20-四[4-(4'-乙基哌嗪基)苯基]卟啉(TEPPH2,8a),5,10,15,20-四[4-(4'-丁基哌嗪基)苯基]卟啉(TBPPH2,8b),5,10,15,20-四[4-(4'-庚基哌嗪基)苯基]卟啉(THPPH2,8c),5,10,15,20-四[4-(4'-苯基哌嗪基)苯基]卟啉(TPhPPH2,8d),5-[4-(4'-乙基哌嗪基)苯基]-10,15,20-三苯基卟啉(EPTPPH2,8e)和5-[4-(4'-丁基哌嗪基)苯基]-10,15,20-三苯基卟啉(BPTPPH2,8f).这些卟啉化合物都由取代苯甲醛与吡咯缩合而成,每一个卟啉分子中含有一个或四个具有抗癌活性的取代哌嗪结构,结构经元素分析,MS,1H NMR,IR和UV-vis等表征.初步的生物活性研究表明,这些化合物具有一定的抗癌活性,因而在医学上可能具有潜在应用前景.     

抗癌活性天然产物Cryptophycins的研究进展

总结了具有强抗癌活性的天然产物cryptophycins及其结构类似物的研究进展, 内容包括cryptophycin的合成、 活性-结构关系规律以及结构类似物的研究情况.     

褐藻糖胶的提取纯化及其抗凝血活性的研究

从海带中提取出的水溶性提取物，经超滤，醇析获得褐藻糖胶粗多糖，以DEAE-Sephrose Fast Flow离子交换层析分离纯化，得到了F1，F2和F3三个级分，这三个级分具有明显的抗凝血作用。尤其是F3级分，能显地延长激活部分凝血活酶时间和凝血酶时间。     

荧光素衍生物抗癌活性的模式识别

近年来,我们以荧光素为母体合成了一系列的衍生物,药理试验证实其中许多种对肿瘤细胞有明显的杀伤和抑制增殖作用。本文用非线性映照(NLM)模式识别技术研究其活性分类,得到分类清晰的映照图,确定了该类衍生物抗ECa 109细胞的主要结构因素,为指导合成新化合物建立了预报模型。 1 结构参数选择与非线性映照     

N-取代靛蓝衍生物的合成及其抗癌活性研究

合成了13种N-取代靛蓝衍生物,其中6种为新化合物.研究了靛蓝的N-取代衍生物与抗痛活性的关系,发现大多数N-取代靛蓝衍生物与靛玉红有相似的抗癌活性,某些甚至离于綻玉红的抗癌活性.     

甘草素的合成及其抗癌活性

以间苯二酚和对羟基苯甲醛为起始原料,经付克酰基化、羟基保护、羟醛缩合、Michael加成及脱保护反应合成了甘草素(1),总收率36.4%,其结构经1HNMR,13C NMR,IR和MS表征。采用MTT法,以5-氟尿嘧啶为阳性对照药,研究了1对人肺腺癌细胞,前列腺癌细胞(DU-145),人胃癌细胞,人结肠癌细胞(HCT-116)及肝癌细胞的抗癌活性。结果表明:1具有较好的抗HCT-116活性,对DU-145也表现了一定的抑制作用。     

胡椒碱-双环酰胺衍生物的设计、合成及抗宫颈癌活性

以胡椒碱为母核进行结构改造,合成了一系列胡椒碱-双环酰胺衍生物;并用核磁共振氢谱(1H NMR),核磁共振碳谱(13C NMR)和高分辨质谱(HRMS)进行了结构确证.噻唑蓝(MTT)比色法测试结果表明,目标化合物对肾细胞(293T)、宫颈癌(HeLa)和乳腺癌(MDA-MB-321)细胞有良好的抑制活性,大多数衍生物对HeLa细胞的抑制活性优于阳性对照药5-氟尿嘧啶(5-FU)和胡椒碱.化合物6b对HeLa细胞的抗增殖活性最高,半数抑制浓度(IC50)为3.49μmol/L,对MDA-MB-321细胞的IC50值为20.89μmol/L.机理研究发现,化合物6b不仅可有效抑制HeLa细胞的迁移、侵袭、黏附和克隆能力,而且对HeLa细胞肿瘤异种移植物的生长表现出强烈的抑制作用.因此,化合物6b有可能成为肿瘤治疗中潜在的先导化合物.     

水溶性卟啉及其系列金属化合物的合成、抗癌活性及其作用机制研究

合成了水溶性四-[(4-三甲铵基)苯基]卟啉TAPP及其金属卟啉化合物MTAPP,其中M=Zn(),Cu(),Fe(),Co(),Ni(),Mn().通过元素分析、紫外-可见光谱确定了化合物的组成和结构.以紫外-可见光谱、荧光光谱及粘度法等手段研究了卟啉化合物TAPP和金属卟啉化合物ZnTAPP与小牛胸腺DNA的相互作用,结果表明,TAPP,ZnTAPP与DNA相互作用使紫外-可见光谱发生了8～12nm的红移,并出现了明显的减色效应.荧光光谱强度明显增大,吸收峰位发生变化.以艾氏腹水癌(Ac)和肝癌(Hept)细胞为靶细胞,采用MTT染色法评价了化合物的抗癌活性,部分化合物表现出较高的抗癌活性     

二苯乙烯衍生物的合成及抗肿瘤活性

以甲氧基取代的4’-氨基二苯乙烯与4-溴甲基-5-甲基-1,3-二氧杂环戊烯-2-酮为原料,通过亲核取代反应合成得到了4种新的二苯乙烯衍生物。这些化合物的结构经NMR、IR和元素分析确定。以HeLa、SMMC-7721、BGC-823和A549为受试细胞株,用MTT法测试了这4种化合物的抗肿瘤活性。测试结果表明,这些化合物具有一定的抗肿瘤活性。     

新型N-甲基吲哚类衍生物的设计、合成及抗肿瘤活性研究

本文以吲哚骨架为起点,设计合成了5个含吲哚骨架的新型有机小分子(4a-4e),通过NMR,IR和MS对目标化合物进行了结构表征.采用MTS法测试了目标化合物对SMMC-7721,Hela,MCF-7和HepG2癌细胞的体外抗肿瘤活性.结果表明,部分化合物选择性地作用于一种细胞,显示出较强的抑制肿瘤细胞增殖的活性,值得进一步研究.     

喜树碱功能化修饰及抗肿瘤活性研究进展

喜树碱是一种重要的天然产物,具有很强的抗肿瘤活性。然而,喜树碱存在水溶性差、在生理条件下易水解而转为无活性的喜树碱羧酸盐等缺陷,限制了其通过静脉注射的临床应用。而对喜树碱的喹啉环、α-羟基内酯环进行功能化修饰可克服上述缺陷。本文就喜树碱结构的功能化修饰及其抗肿瘤活性进行了综述,以期为其他研究人员更快地开发出具有高效、低毒的新型喜树碱类抗癌药物提供参考。     

Synthesis,characterization, and antitumor activity of mononuclear and dinuclear ruthenium complexes

Abstract

Dinuclear ruthenium complexes [Ru₂(bpy)₄BL](ClO₄)₂ (Ru-1), where bpy = 2,2′-bipyridine and BL = 2,2′-((1E,1′E)-((E)-diazene-1,2-diyl-bis(2,1-phenylene))-bis(azanylylidene))bis(methanylylidene))diphenol (a bidentate bridging ligand), and mononuclear ruthenium complexes [Ru(bpy)₂L](ClO₄) (Ru-2), where L = (E)-2-((phenylimino)methyl)phenol, were synthesized and characterized by elemental analysis and electrospray ionization mass spectrometry. Their photophysical and electrochemical properties were also studied. The cytotoxicity of the two complexes in vitro was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The results indicated that Ru-1 and Ru-2 exhibited significant dose-dependent cytotoxicity to human breast cancer (MCF-7), gastric cancer (SGC-7901), cervical cancer (Hela), and lung cancer (A549) tumor cell lines. Ru-1 showed excellent antitumor effects in a cellular study (IC₅₀ values of 3.61 μM for MCF-7 human breast cancer cells in vitro). However, Ru-2 exhibited the highest cytotoxicity to Hela cells; the IC₅₀ value is 3.71 μM. The results reveal that Ru-1 and Ru-2 have obvious selectivity and might be a potential anticancer agent that could improve the efficacy of common anticancer therapies.     

Synthesis and antitumor activity of camptothecin- 4β-triazolopodophyllotoxin conjugates

Abstract

Two new compounds (9 and 10) having a camptothecin (CPT) analog conjugated to the 4β-azido-4-deoxypodophyllotixin analog by untilizing the copper-catalyzed azide-alkyne cycloadditon (CuAAC) reaction, and were evaluated for their cytotoxicity against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7 and SW480) using the MTT (3-(4,5-dimethyl-thiahiazo-2-yl)-2,5-diphenyltetrazolium bromide) assay. Two novel conjugates shown weak cytotoxicity, compound 10 showed highly potent against HL-60 cell line tested, with IC₅₀ value 17.69?±?0.19?μM. This compound suggested its potential as anticancer agents for further development.

     

Synthesis,antioxidant and antitumor activities of some of new cyclobutane containing triazoles derivatives

Abstract

Thiosemicarbazides (2a–e) were obtained by the interaction of furan-2-carboxylic acid hydrazide (1) with five different isothiocyanate (RNCS) derivatives. By addition of KOH to the reaction medium, ethyl, allyl, phenyl and benzyl, p-tolyl substituted 1,2,4-triazoles (3a–e) were obtained. 3a–e were dissolved in dry acetone containing K₂CO₃ in the presence of 2-chloro-1-(3-methyl-3-mesitylcyclobutyl) ethanone (4) to give 3,4,5-trisubstituted 1,2,4-triazole sulfanyl compounds containing a cyclobutane ring (5a–e). The structures of the final compounds were confirmed by elemental analyses, FT-IR, ¹H-NMR and ¹³C-NMR. The antioxidant and antitumor properties of the synthesized compounds were also investigated. Three of the triazole derivatives with p-tolyl, benzyl and phenyl substituents (5c–e) displayed good antioxidant and antitumor activity in comparison to the standards.     

一种萘酰亚胺衍生物的合成及其体外抗癌活性测定

合成了萘酰亚胺衍生物2-[2-(二甲基氨基)乙基]-6-2-(2-羟乙胺基)乙胺基-1H-苯并异喹啉-1,3(2H)-二酮;利用元素分析、核磁共振谱及质谱分析了其组成和结构;利用MTT法测定了其对人肝癌细胞(HepG2)、人乳腺癌细胞(MDA-MB-231)及人结肠癌细胞(HCT-116)的体外活性.结果表明,标题化合物的体外抗肿瘤活性优于对照品氨萘非特.     

Synthesis,characterization of diorganotin (IV) schiff base complexes and their in vitro antitumor activity

Six novel diorganotin(IV) complexes have been synthesized in good yields by the reaction of R₂SnCl₂ (R= methyl, phenyl) with the Schiff base derived from salicylaldehyde and substituted thiosemicarbazide. The complexes were characterized by elemental analysis, IR, ¹H NMR and MS spectra. The structure of 2f was confirmed by single crystal X‐ray diffraction. The crystal of 2f is triclinic, space group P‐1 with a = 0.84996(12), b = 1.1204(2), c = 1.27597(12) nm, β = 81.908(9)°, V=1.0904(2) nm³, Z = 2, D_c= 1.551 g/cm³. The final discrepancy factors are R = 0.0211 and R_w = 0.0536 for 3710 independent reflections. Tests of antitumor activities in vitro showed that the obtained complexes had relative inhibition interaction to the KB, HCT‐8 and BEL‐7402 tumor cell lines.     

Synthesis and antitumor activity of novel pyridazinone derivatives containing 1,3,4-thiadiazole moiety

Abstract

A series of novel pyridazinone derivatives containing the 1,3,4-thiadiazole moiety were synthesized and characterized by ¹H NMR, 13C NMR, spectroscopies HRMS and IR. Among them, the structure of compound 5c (2-(Tert-butyl)?4-chloro-5-((5-((2-ethylphenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One) was unambiguously confirmed via single crystal X-ray diffraction analysis. The inhibitory activity of all the target compounds against MGC-803 and Bcap-37 was determined by MTT assay, with doxorubicin (the inhibition rates were 95.5?±?0.4% and 95.7?±?1.0% respectively) as a control. The preliminary results showed that the inhibitory activity of compound 5n (2-(Tert-butyl)?4-chloro-5-((5-((3-fluorophenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One) was superior to the others. The inhibition rates of MGC-803 and Bcap-37 cells were 86.3?±?2.2% and 92.3?±?0.6% at a concentration of 10?μmol/L, respectively. The preliminary structure-activity relationship showed that when the 2-position of the benzene ring was substituted by a methyl group, such as compound 5j (2-(Tert-butyl)?4-chloro-5-((5-((2,3-dimethylphenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One), it exhibited good anticancer activity on MGC-803 cells. Besides, introducing fluorine, chlorine, or trifluoromethyl group onto the benzene ring, such as compound 5?m (2-(Tert-butyl)?4-chloro-5-((5-((4-(trifluoromethoxy)phenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One), displayed good anticancer activity on MGC-803 and Bcap-37 cells.     

氟代索拉非尼的合成及其抗肿瘤活性研究

以N-甲基-4-氯-2-吡啶甲酰胺为原料,经过4步共合成4个化合物(S-1,S-2,R-1和R-2),其中2个为新的化合物(S-1和R-2)。经过1H NMR,13C NMR,HR-MS等方法对其结构表征。最后通过CTG法,测试4种化合物对四种人肝癌细胞(PLC/PRF/5,Hep3B,HepG2,BEL-7402)的抑制活性。结果表明:S-1,S-2,R-1和R-2均表现较明显的对4种细胞的抑制活性,且呈现出浓度依赖关系。IC50值从1304nM到11228nM。其中化合物R-1(瑞格非尼)对PLC/PRF/5和HepG2细胞,S-1对Hep3B细胞的抑制活性,R-2对HepG2的细胞活性均较高于原药索拉非尼。